Schedule 13G ownership disclosure

OnKure Therapeutics, Inc.

Security class unavailable · CUSIP: 68277Q105

Event date: 2024-10-04

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
3.4400%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000929638-24-003523
Form type
SC 13G/A
Filer
Cormorant Asset Management, LP
CIK
CIK 1583977
Filed
Oct 16, 2024
Reporting period
Oct 04, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub